Functional damage of endothelial progenitor cells is attenuated by 14‐3‐3‐n through inhibition of mitochondrial injury and oxidative stress

Yunde Li,Xinglan Sun,Xuemei Zhang,Hui Zhou,Dan Wang,Yi Xia,Xiuli Li
DOI: https://doi.org/10.1002/cbin.11529
IF: 4.473
2020-12-25
Cell Biology International
Abstract:<p>Endothelial progenitor cells (EPCs) are precursor cells of vascular endothelial cells, which are widely involved in the pathological process of cardiovascular diseases. EPCs apoptosis could accelerate the process of cardiovascular diseases. 14‐3‐3‐η protein has been proved to be a potent anti‐apoptosis molecule. However, inhibition of EPCs apoptosis by 14‐3‐3‐η and further specific mechanism have not been investigated. EPCs were isolated from human cord blood, and identified using VEGFR2 and CD34. 14‐3‐3‐η overexpression model in vitro was established. Cell invasion, apoptosis, and proliferation were measured by transwell, flow cytometry, and CCK‐8, respectively. Expression of 14‐3‐3‐η, Bcl‐2, and voltage‐dependent anion channel 1 (VDAC1) were measured using qRT‐PCR and western blotting. Reactive oxygen species (ROS) intensity was measured using DCFH‐DA probe. Mitochondrial membrane potential was detected using JC‐1 dye. Overexpression of 14‐3‐3‐η significantly promoted invasion and proliferation, but suppressed apoptosis of EPCs. Overexpression of 14‐3‐3‐η remarkably inhibited ROS and promoted antioxidant enzyme levels in EPCs. 14‐3‐3‐η might inhibit apoptosis of EPCs through attenuating mitochondrial injury. This study might provide a new target, 14‐3‐3‐η, for the prevention and treatment of cardiovascular diseases through targeting EPCs.</p><p>This article is protected by copyright. All rights reserved.</p>
cell biology
What problem does this paper attempt to address?